I am going to make an assumption and as we all know there

New Post Public Reply Private Reply Replies (0) Message Board
Machiavelli20 freeranger #1893
I am going to make an assumption and as we all know there are dangers in doing so. The assumption is that we are in the middle of a process in which the N-Assay is being finalized and the Faro's are nearing the completion of a critical stage of their testing and should be close to reporting on such. Added to this is the fact that NanoLogix has an agreement with a Singaporean partner that is well-positioned to market the packaging tech inside China to locations in absolute need of the product's special capacities and the ability to pay for and use it in volume. I am also going to assume that as we have seen in prior reports that marketing and sales are developing and we hope revenues expanding. BUT those revenues will only be positive in relation to raising the share price when they are closer to something dramatic. In other words, those of us holding the shares should not want to see financial information until a strategic point when that $$ level is at the point where it has the ability to "move the market" on share prices. Right now the trading volume is low because we are treading water and unwilling to sell at prices that are likely significantly lower than share prices will be when and if the sales of the close to emerging N-Assay and packaged petri dishes with long life under harsh conditions start on a steep upward curve. This doesn't even begin to deal with the possibility of a partnership with a significant medical supplies company (or a sale) although the N-Assay's potential makes those possibilities more probable.

So, I don't want to see financials until they are sufficient to drive the share price upward. Once they are then we can also see if there is momentum for upgrading the stock classification so that the shares are traded on a more significant market than at the present time.

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Innovative Nonprofit Incubation Strategies by NVF

Updated Category News Views 252

Exploring Innovative Nonprofit Incubation Strategies by NVF Today, New Venture Fund has brought forth a significant report highlighting the nonprofit incubation process, titled "Growing Change: How New Venture Fund Incubates Nonprofits to Make Lasting Impact." This report sheds light on the intricacies of incubation, showcasing the essential characteristics of successful...

Continue Reading
Julio Herrera Velutini Exonerated in Major Legal Battle

Updated Category News Views 439

Resolution of Legal Matters for Julio Herrera Velutini Following extensive and rigorous legal proceedings, Venezuelan-British banker, Julio Herrera Velutini, experienced a significant and favorable resolution in his legal case. This outcome follows more than three years of intense scrutiny regarding allegations against him, specifically targeting serious criminal charges....

Continue Reading
The Rise of Height-Adjustable Desks by 2029: What You Need to Know

Updated Category News Views 124

Growth Perspective on Height-Adjustable Desks The market for contemporary height-adjustable desks has been thriving, reflecting an expected increase of USD 2.75 billion by 2029. This surge is significantly driven by the growing demand for modern desks that promote better ergonomics in both office and home environments. This trend is part of a larger movement towards...

Continue Reading
Barnwell Industries Faces 52-Week Low: A Turning Point

Updated Category News Views 57

Barnwell Industries Inc Stock Performance Review Barnwell Industries Inc (BRN) has recently encountered a challenging period, highlighted by its stock touching a 52-week low at $1.99. This significant decrease in stock value is alarming for investors and stakeholders alike. Over the past year, Barnwell's share price has plummeted by 21.48%, a clear indication of bearish...

Continue Reading
Exploring Advanced Oncology Solutions at Altogen Labs

Updated Category News Views 214

Innovative Approaches to Oncology at Altogen Labs Altogen Labs stands out as a premier preclinical research organization focused on propelling the field of oncology forward. They dedicate themselves to the innovative testing and evaluation of new treatments. With an emphasis on pharmacological and biological therapies, Altogen Labs aims to deliver groundbreaking...

Continue Reading